Dr. Lal Path Labs Share Price

₹ 1,925.70

+₹38.50 (2.04%)
1D
Last updated 03 Nov, 2026, 15:52 IST
NSE: LALPATHLAB
|
Healthcare Services

Dr. Lal Path Labs Share Price Today

As of 3 Nov 2026, Dr. Lal Path Labs share price is ₹1,925.70. The stock opened at ₹1,887.20, compared to its previous close of ₹1,887.20. During today's trading session, Dr. Lal Path Labs share price moved in the range of ₹1,877.20 to ₹1,936.00, with an average price of ₹1,906.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,272.60 and a high of ₹2,038.60.

Share price over the last 1 day rose from 1897.70 to 1916.10, ranging between 1877.20 and 1934.60.
₹1,877.20
2.04% up today
₹1,936.00
1D LOW
1D HIGH

Dr. Lal Path Labs Stock Insights

Latest Earning
Op Profit TrendUp by 42.85% QoQ
Latest Earning
Net Profit TrendUp by 28.97% QoQ
Latest Earning
Revenue TrendUp by 14.16% QoQ
Stock Performance
OutperformingBeat Nifty by 5.52 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.48%
Shareholding Pattern
DIIDII increased stake by 3.28%
Shareholding Pattern
FIIFII increased stake by 7.93%
Dr. Lal Path Labs stock performance
Open₹1,887.20
High₹1,936.00
Low₹1,877.20
Prev. close₹1,887.20
Dr. Lal Path Labs trading activity
Volume2,31,854
Average traded price₹1,915.86
Last traded time03:52:11 03 Nov
Last traded quantity3
Circuit
L
H
₹1,509.80
₹2,264.60
52-week
L
H
₹1,272.60
₹2,038.60
Mkt Cap Cr
31,681.46
P/E
57.99
P/B
12.63
ROA
17.36%
ROE
20.13%
ROCE
25.56%
Quick Ratio
3.38
EV/EBITDA
34.28

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Dr Lal Pathlabs has underperformed the market
Valuation: 3 out of 5, Fairly Valued
Valuation
Fairly Valued
Dr Lal Pathlabs appears to be fairly valued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Dr Lal Pathlabs revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,21,066.6855.7412.779.79%20.48%17.27%0.9830.42
Manipal Health Enterprises Limited87,926.3994.845.234.07%10.59%9.51%1.1734.66
Max Healthcare83,704.6862.287.597.37%12.18%13.24%0.8433.68
Aster DM Healthcare58,742.01162.013.964.47%8.48%10.1%1.966.59
Fortis Healthcare57,376.8253.65.86.7%10.53%12.56%0.828.03
Narayana Hrudayalaya35,143.9343.77.56.43%17.17%12.26%2.0719.68
Global Health34,121.9063.238.819.35%14.05%15.26%2.5432.32
KRISHNA INST OF MED SCI L29,480.26155.698.082.51%10.74%7.99%0.6839.1
Syngene International16,251.7289.533.432.79%5.47%7.06%1.2922.34
DR AGARWALS HEALTH CARE L16,116.9588.048.054.7%6.58%9.75%1.0426.24

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Dr. Lal Path Labs Company Background

ISIN
INE600L01024
Sector Market Cap
₹ 31,681.46 Cr

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.

Dr. Lal Path Labs Financial Highlights

  • Revenue: Dr. Lal Path Labs reported revenue of ₹2,864.20 crore in FY26 vs ₹2,554.80 crore in FY25. It showed an increase of 12.11% on a yearly basis.
  • Operating Profit: Dr. Lal Path Labs reported an operating profit of ₹669.10 crore in FY26 vs ₹624.70 crore in FY25. It showed an increase of 7.11% on a year-on-year basis.
  • Net Profit: Dr. Lal Path Labs reported a net profit of ₹509.80 crore in FY26 vs ₹492.20 crore in FY25. It showed an increase of 3.58% on a yearly basis.

Dr. Lal Path Labs Quarterly Result Highlights

  • Dr. Lal Path Labs reported revenue of ₹829.60 crore in Jun 2026, compared with ₹726.70 crore in Mar 2026, representing an increase of 14.16% on a quarter-on-quarter (QoQ) basis.
  • Dr. Lal Path Labs reported an operating profit of ₹228.70 crore in Jun 2026, compared with ₹160.10 crore in Mar 2026, representing an increase of 42.85% on a quarter-on-quarter (QoQ) basis.
  • Dr. Lal Path Labs reported a profit of ₹170.50 crore in Jun 2026, compared with ₹132.20 crore in Mar 2026, reflecting an increase of 28.97% on a QoQ basis.
  • The earnings per share (EPS) of Dr. Lal Path Labs stood at ₹30.24 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
52.93%
FII
18.73%
Other DII
2.89%
Retail and other
6.76%
Mutual funds
18.68%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202520.29%
Mar 202617.18%
Jun 202617.36%
Sep 202618.73%

Dr. Lal Path Labs Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Dr. Lal Path Labs Share Price History

Dr. Lal Path Labs share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,906.40 / ₹1,887.20
-1.01%
30 Oct 26
₹1,911.70 / ₹1,906.40
-0.28%
29 Oct 26
₹1,925.00 / ₹1,911.70
-0.55%
28 Oct 26
₹1,885.20 / ₹1,922.30
+1.08%
Show more

Dr. Lal Path Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,762.91₹2,461.40₹2,226.64₹2,016.88
Other Income₹101.27₹93.43₹69.17₹41.72
Total Revenue₹2,864.18₹2,554.83₹2,295.81₹2,058.60
Total Expenses₹2,165.00₹1,930.03₹1,790.36₹1,714.77
Profit Before Tax₹669.09₹624.80₹505.45₹343.83
Tax₹159.33₹132.55₹143.16₹102.75
Profit After Tax₹509.75₹492.25₹362.29₹241.08
EPS - Basic₹30.24₹58.48₹43.05₹28.82
EPS - Diluted₹30.20₹58.40₹42.98₹28.74

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹509.75₹492.25₹362.29₹241.08
Income before WC changes₹784.37₹731.66₹631.63₹526.99
Change in Assets-₹37.43-₹17.61-₹12.84₹25.09
Change in Liabilities₹64.05₹18.73₹48.58₹10.38
Change in WC₹26.62₹1.12₹35.74₹35.48
Cash flow from Operations₹635.61₹568.89₹535.33₹456.03
Cash flow from Investing-₹421.86-₹303.16-₹24.27-₹287.31
Cash flow from Financing-₹263.57-₹334.03-₹413.86-₹283.18
Total Cash Flow-₹49.83-₹68.31₹97.20-₹114.46
Cash (Start of the year)₹292.63₹360.93₹263.73₹378.20
Cash (End of the year)₹242.80₹292.63₹360.93₹263.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,579.50₹1,353.28₹1,329.27₹1,412.48
Current Assets₹1,566.49₹1,363.51₹1,126.70₹973.09
Total Assets₹3,146.00₹2,716.79₹2,455.96₹2,385.56
Current Liabilities₹450.62₹402.35₹465.19₹469.75
Net Current Asset₹1,115.88₹961.16₹661.51₹503.33
Non-Current Liabilities₹154.10₹107.96₹105.41₹216.26
Equity Capital₹2,541.28₹2,206.48₹1,885.36₹1,699.55
Total Equity & Liabilities₹3,146.00₹2,716.79₹2,455.96₹2,385.56

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,647.57₹2,351.62₹2,125.06₹1,769.03
Other Income₹112.74₹111.52₹66.30₹46.60
Total Revenue₹2,760.31₹2,463.14₹2,191.37₹1,815.63
Total Expenses₹2,069.97₹1,841.86₹1,708.84₹1,424.80
Profit Before Tax₹660.25₹621.28₹482.53₹390.83
Tax₹152.04₹124.02₹135.80₹98.47
Profit After Tax₹508.21₹497.27₹346.73₹292.36
EPS - Basic₹30.45₹29.85₹41.72₹35.28
EPS - Diluted₹30.40₹29.81₹41.66₹35.17

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹508.21₹497.27₹346.73₹292.36
Income before WC changes₹755.46₹700.92₹602.75₹487.14
Change in Assets-₹44.63-₹24.29-₹18.35₹19.61
Change in Liabilities₹61.66₹18.00₹48.02₹19.91
Change in WC₹17.03-₹6.29₹29.67₹39.52
Cash flow from Operations₹605.87₹540.00₹504.60₹427.53
Cash flow from Investing-₹382.09-₹293.00₹1.17-₹288.47
Cash flow from Financing-₹255.95-₹324.75-₹410.53-₹270.05
Total Cash Flow-₹32.17-₹77.75₹95.24-₹130.99
Cash (Start of the year)₹266.60₹344.34₹249.10₹351.31
Cash (End of the year)₹234.43₹266.60₹344.34₹220.32

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,554.56₹1,343.67₹1,312.77₹1,510.00
Current Assets₹1,494.59₹1,277.28₹1,036.39₹810.17
Total Assets₹3,049.15₹2,620.95₹2,349.16₹2,320.17
Current Liabilities₹434.44₹388.44₹450.47₹432.16
Net Current Asset₹1,060.16₹888.85₹585.92₹378.01
Non-Current Liabilities₹141.89₹98.28₹97.97₹198.15
Equity Capital₹2,472.83₹2,134.23₹1,800.72₹1,689.86
Total Equity & Liabilities₹3,049.15₹2,620.95₹2,349.16₹2,320.17
* All values are in INR Crore
Dr. Lal Path Labs market depth
Bid quantityBid priceAsk priceAsk quantity
001925.738
0000
0000
0000
0000
Total bid quantity0
Total ask quantity38
Dr. Lal Path Labs technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
47.51
Neutral
ATR (14)
62.01
Neutral
STOCH(9,6)
55.81
Neutral
STOCH RSI (14)
60.72
Neutral
ADX(9)
21.14
Bearish
UO(9)
61.15
Neutral
ROC(12)
-2.62
Bearish
WillR(14)
-53.17
Neutral
Period
Simple value
Exponential vaue
5D
1905.88
1895.03
10D
1874.67
1891.96
20D
1901.16
1898.07
50D
1914.06
1890.36
100D
1833.71
1822.84
Volume trend — traded volume by day
3 Nov2L
2 Nov1L
30 Oct2L
29 Oct2L
28 Oct1L
27 Oct2L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Dr. Lal Path Labs
Healthcare Services
Add Stock
Add Another

Mutual Funds Invested in Dr. Lal Path Labs

Fund name
AUM
Tata India Innovation Fund
3.19%
PGIM India Healthcare Fund
2.83%
Bandhan Healthcare Fund
2.76%

Dr. Lal Path Labs Returns Calculator

Ex-date: 30 Jul 2026
Ex-date: 25 Jun 2026
Ex-date: 05 Feb 2026
Ex-date: 19 Dec 2025
Ex-date: 07 Nov 2025

Dr. Lal Path Labs Latest News

2 weeks ago
Apollo Hospitals, Max Health, Fortis: Healthcare stocks to post strong Q2 earnings; volumes, capacity additions in focus
1 month ago
Stocks to watch, Sept 25: PB Fintech, SAIL, Sedemac Mechatronics, Dr Lal Pathlabs, Genesys International, Wheels India
1 month ago
Tata Chemicals, 3M India, Patanjali Foods shares spurt amid spike in volumes; check full list
3 months ago
Dr. Lal Path Labs shares hit 52-week high on highest quarterly revenue growth in 4 years; here's what Morgan Stanley analysts said
3 months ago
SENSEX, NIFTY50 extend losing streak to 5th day as crude surge, fresh US tariffs weigh
3 months ago
Dr. Lal Path Labs Q1 profit jumps 28% YoY, dividend of ₹5 apiece declared; shares gain over 2%
6 months ago
Dr Lal Path Labs shares jump 20% on strong buying cue post Q4 results; factors fuelling today’s gains
Showing news item 1 of 7

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Dr. Lal Path Labs Share Price FAQs

Please be aware that Dr. Lal Path Labs stock prices are subject to continuous fluctuations due to various factors.